Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Silexan in the Treatment Of Posttraumatic Stress Disorder (STOP) Trial

NCT06412757 is registered in ClinicalTrials.gov with Deakin University as lead sponsor.

NCT NCT06412757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06412757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Silexan in the Treatment Of Posttraumatic Stress Disorder (STOP) Trial
Lead sponsor
Deakin University
Phase
Phase 3
Overall status
Recruiting
Start date
August 26, 2024
Completion date
June 30, 2027
Enrollment
278 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder